Guided self-help for anxiety among Huntington's disease gene expansion carriers (GUIDE-HD) compared to treatment as usual: a randomised controlled feasibility trial.

Maria DaleFiona J R EcclesKatie MelvinZaynah KhanLee JonesNicolò ZarottiReza KianiJenny JohnsonRobert WellsJane Simpson

Published in: Pilot and feasibility studies (2023)

Trial ID: ISRCTN47330596 . Date registered: 28/09/2022. Protocol version and date: Version 2, 09/06/22. Trial sponsor organisation and contact: Leicestershire Partnership NHS Trust (Dave Clarke). Role of sponsor: Overall responsibility for the conduct and governance of the trial. Role of funder: Review of initial research proposal.

Keyphrases

study protocol
phase iii
phase ii
clinical trial
randomized controlled trial
open label
healthcare
gene expression
public health
copy number
depressive symptoms
transcription factor
smoking cessation
sleep quality
combination therapy